Quick-Med Technologies, Inc. Signs Manufacturing and Distribution Agreement with BASF Beauty Care Solutions
Quick-Med Technologies zu myNews hinzufügen Was ist das?
Quick-Med Technologies, Inc. (OTCBB:QMDT) announced today that it
has entered into a new multi-year exclusive worldwide Manufacturing and
Distribution Agreement with BASF Beauty Care Solutions, L.L.C., to
manufacture and distribute Quick-Med’s
proprietary anti-aging technology MultiStat for use in cosmetics.
BASF Beauty Care Solutions is the premier provider of active ingredients
and advanced formulations to the global cosmetics industry. It is a unit
of BASF Group, the world’s largest chemical
company and the world leader in active ingredients and encapsulation
systems for skin care.
MultiStat is Quick-Med’s proprietary family of
compounds – generally called Matrix
Metalloproteinase Inhibitors – that represent
a new frontier in anti-aging skin care. BASF will focus on one
particular advanced and patented compound that has been shown to
significantly benefit the appearance and maintenance of skin in more
than 250 research studies and academic papers.
MMP Inhibitors have been proven effective in broad-based applications,
including improving the appearance of fine lines and wrinkles associated
with natural aging or sun-induced premature aging and damage. In
addition to exclusive rights to the compounds themselves in its target
markets, Quick-Med now also owns the exclusive right to use MMP
Inhibitors for key anti-aging products based on its license agreement
with the University of Michigan signed in 2007.
"As the premier supplier to the cosmetics
industry, BASF is the ideal partner to achieve MultiStat’s
exciting market potential." said J. Ladd Greeno, CEO of Quick-Med
Technologies. "Our new agreement
with BASF Beauty Care Solutions marks an important milestone for
Quick-Med Technologies. And our exclusive rights to use this important
technology in anti-aging products should help drive our success.”
The new agreement supersedes previous agreements between the two
companies and provides a basis of collaboration through December 31,
2010.
About BASF Group
BASF is the world’s leading chemical company:
The Chemical Company. Its portfolio ranges from oil and gas to
chemicals, plastics, performance products, agricultural products and
fine chemicals. As a reliable partner BASF helps its customers in
virtually all industries to be more successful. With its high-value
products and intelligent solutions, BASF plays an important role in
finding answers to global challenges such as climate protection, energy
efficiency, nutrition and mobility. BASF has more than 95,000 employees
and posted sales of almost €58 billion in
2007. BASF shares are traded on the stock exchanges in Frankfurt (BAS),
London (BFA) and Zurich (AN). Further information on BASF is available
at www.basf.com. About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is
developing innovative technologies for the healthcare and consumer
markets. For more information, see: www.quickmedtech.com.
© 2008 Quick-Med Technologies, Inc. All
rights reserved. MultiStat™ is a trademark of
Quick-Med Technologies, Inc.
Forward-looking statements (statements which are not historical
facts) in this release are made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. For this
purpose, any statements contained in this release that are not
statements of historical fact may be deemed to be forward-looking
statements. Without limiting the generality of the foregoing, words such
as "may", "will", "to", "expect", "plan", "believe", "anticipate",
"intend", "could", "would", "estimate", and/or "continue" or the
negative or other variations thereof or comparable terminology is
intended to identify forward-looking statements involve risks and
uncertainties, including those risks that are discussed in the Company's
filings with the Securities and Exchange Commission ("SEC"), which may
be accessed at the SEC's Edgar System at www.sec.gov.